A. Cavey

发表

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease

E. Schiffer, Jacqueline A Palace, N. Sibson, 2017, Acta neuropathologica communications.

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels

H. Johansen-Berg, C. Stagg, Jacqueline A Palace, 2010, Epilepsia.

Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.

Jacqueline Palace, P. Rothwell, N. Evangelou, 2016, JAMA neurology.

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.

Jacqueline A Palace, Su-Hyun Kim, H. Kim, 2021, Multiple Sclerosis and Related Disorders.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2021, The Lancet.

The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease

Jacqueline Palace, A. Vincent, L. Clover, 2004 .

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Nguyen H. Tran, Andreas C. Themistocleous, David J. Smith, 2020, Lancet.

Serum antibodies in epilepsy and seizure-associated disorders

J. Palace, Jacqueline A Palace, Y. Shoenfeld, 2005, Neurology.

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis

M. Turner, G. Wilcock, J. Griffin, 2014, Neurology.

A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis

H. Dawes, D. Wade, Jacqueline A Palace, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

A protocol for a randomised double-blind placebo-controlled feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue in people with relapsing and remitting multiple sclerosis (RRMS)

H. Dawes, D. Wade, J. Palace, 2018, Pilot and Feasibility Studies.

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

J. Knight, V. Libri, A. Mentzer, 2022, Nature Medicine.

An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue

A. Winkler, I. Tracey, Y. Kong, 2021, NeuroImage.

Multiple sclerosis in Japan appears to be a milder disease compared to the UK

Y. Kong, K. Fujihara, Jacqueline A Palace, 2015, Journal of Neurology.

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

Adam L. Comer, Robert G. Miller, S. Demeret, 2023, The Lancet Neurology.

Classifying the antibody-negative NMO syndromes

Jacqueline Palace, D. Anthony, T. Claridge, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.

M. Jenkinson, V. Tomassini, À. Rovira, 2013, Brain : a journal of neurology.

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis

M. Jenkinson, Jacqueline A Palace, M. Calabrese, 2020, medRxiv.

OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis

P. Matthews, J. Hobart, C. Blain, 2021, BMJ Open.

Physical Activity and Fatigue in Multiple Sclerosis: Secondary Outcomes from a Double-blinded Randomized Controlled Trial of Cocoa Flavonoid Drinks

H. Dawes, J. Palace, M. Mansoubi, 2021, Translational Medicine and Exercise Prescription.

An optimal 1H-MRS technique at 7T: Proof-of-principle in Chronic Multiple Sclerosis and Neuromyelitis Optica Brain Lesions and Normal Appearing Brain Tissue.

A. Winkler, Jacqueline Palace, I. Tracey, 2020, medRxiv.

Hydration and independence in activities of daily living in people with multiple sclerosis: a pilot investigation

H. Dawes, D. Wade, C. Sackley, 2011, Disability and rehabilitation.